Greg Yedinak

Outlook CloudFlare Hosting Salesforce Mobile Friendly WordPress.org Gravity Forms Google Font API Google Tag Manager Greenhouse.io Remote

biotechnology research cytokine therapeutics selective cytokine immunotherapy stk-012 stk-009 syncar-001 orthogonal il-2 cancer treatment autoimmune disease inflammatory disease biased agonists partial agonists cell therapy surrogate cytokine immunomodulatory tumor regression antigen-activated t cells drug development clinical trials fda approval protein engineering biotechnology next-generation therapeutics therapeutic index cytokine biology tumor microenvironment therapeutic candidates dose-limiting toxicities expression of cytokine receptors cytokine signaling clinical efficacy immune cell communication safety profile preclinical studies adoptive cell therapies dimerization cell selectivity oncolytic therapies multi-platform approach immunology expertise therapeutic potential patient access biopharmaceutical innovation continuous improvement investigational drugs clinical investigations pharmaceutical development strategic partnerships cross-functional collaboration health care health wellness & fitness hospital & health care